Drug Type Gene therapy |
Synonyms EP53 protein-loaded nanoparticles (PEEL Therapeutics) |
Target |
Action modulators |
Mechanism TP53 gene modulators(Tumor protein p53 gene modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Osteosarcoma | Preclinical | United States | 01 Sep 2018 | |
| Solid tumor | Discovery | United States | 18 Apr 2024 |





